Oxford Medical Simulation (OMS) has successfully completed a £10 million ($12.6 million) Series A funding round, led by Frog Capital and with participation from ACF Investors, existing shareholders, and strategic partners. This funding marks a significant milestone for OMS, a pioneer in virtual reality healthcare training, as it strives to revolutionize healthcare education, training, and assessment. OMS is dedicated to addressing the training gap in healthcare by offering immersive training experiences that allow healthcare professionals to practice without risk, anytime and anywhere. This not only enhances preparedness for practice but also improves patient safety. Additionally, OMS reduces staffing and equipment costs by 74% compared to traditional training methods. With this investment, OMS plans to scale its offerings, expand the use of AI, and continue innovating in healthcare training.
Founded in 2017, OMS partners with top institutions to support healthcare professionals throughout their careers.
By delivering over 35,000 simulations per month, OMS has proven its effectiveness in training, saving costs, and improving patient care. The recent funding will enable OMS to scale its team, collaborate with clients to build content, and further its research and development efforts. Frog Capital, known for helping scale impact-focused software companies, will provide valuable support as OMS expands. Michael Wallace, co-founder and CEO of OMS, expressed excitement about the investment and its potential to make a significant impact on healthcare education and patient care.
OMS designs, builds, and delivers virtual reality healthcare training using VR headsets. Learners can practice in fully-immersive and interactive clinical scenarios, receiving personalized feedback to improve their performance. These standardized training scenarios benefit students, doctors, nurses, and other healthcare professionals, enabling them to improve patient care without risking lives. OMS works with over 150 healthcare training institutions worldwide, demonstrating its commitment to enhancing training and patient outcomes.
Click here for a full list of 6,481+ startup investors in the UK